Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
INMB similar filings
- 4 Mar 20 INmune Bio, Inc. Schedules Conference Call to Report 2019 Fourth Quarter and Full Year Financial Results
- 10 Feb 20 INmune Bio, Inc. Awarded $500,000 Grant for Development of Novel Treatment to Reprogram Innate Immune System in People Living with ALS
- 27 Jan 20 Entry into a Material Definitive Agreement
- 13 Jan 20 Regulation FD Disclosure
- 2 Jan 20 INmune Bio, Inc. Announces Data on its Lead Compound Which Highlights The Potential to Lower The Risk of Alzheimer’s Disease in Obese Individuals
- 17 Dec 19 Regulation FD Disclosure
- 3 Dec 19 INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study
Filing view
External links